In rare diseases, 10 participants data is significant. In some diseases you may be hard pressed getting 50 participants worldwide through trial centres. Gastric Cancer is not a rare disease, unfortunately, particularly in Asia. Looking forward to Ph2.
IMU Price at posting:
1.9¢ Sentiment: Buy Disclosure: Held